Home › NDC Lookup › RxCUI directory › RxCUI 2265721

1 ML givosiran 189 MG/ML Injection [Givlaari] — RxCUI 2265721

Name: 1 ML givosiran 189 MG/ML Injection [Givlaari] (RxCUI 2265721)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2265721 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2265721

Official name1 ML givosiran 189 MG/ML Injection [Givlaari]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as1 ML Givlaari 189 MG/ML Injection; GIVLAARI 189 MG in 1 ML Injection; Givlaari 189 MG per 1 ML Injection

FDA products mapped1

Package NDCs mapped1

Reported Medicaid activity (SDUD)202 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How 1 ML givosiran 189 MG/ML Injection [Givlaari] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 1 ML givosiran 189 MG/ML Injection [Givlaari] RxCUI 2265721 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Givosiran 2265712 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Givlaari 2265717 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Givosiran Injection 2265715 SCDF
- Givosiran Injectable Product 2265714 SCDG
- Givosiran Injection [Givlaari] 2265719 SBDF
- Givlaari Injectable Product 2265720 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 1 ML givosiran 189 MG/ML Injection 2265716 SCD
- Givosiran 189 MG/ML 2265713 SCDC
- Givosiran 189 MG/ML [Givlaari] 2265718 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

1 ML givosiran 189 MG/ML Injection SCD · 2265716
Givosiran 189 MG/ML SCDC · 2265713
Givosiran Injection SCDF · 2265715
Givosiran Injectable Product SCDG · 2265714

Brand-Name Concepts

Givosiran 189 MG/ML [Givlaari] SBDC · 2265718
Givosiran Injection [Givlaari] SBDF · 2265719
Givlaari Injectable Product SBDG · 2265720
Givlaari BN · 2265717

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 2265721 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
71336-1001-01	1 VIAL, SINGLE-USE in 1 CARTON (71336-1001-1) / 1 mL in 1 V...	GIVLAARI	Alnylam Pharmaceuticals, Inc.	2019-12-12

Observed labelers: Alnylam Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0223	Inj givosiran 0.5 mg	1	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.